BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 31597510)

  • 1. Screening of Antitubercular Compound Library Identifies Inhibitors of Mur Enzymes in
    Eniyan K; Rani J; Ramachandran S; Bhat R; Khan IA; Bajpai U
    SLAS Discov; 2020 Jan; 25(1):70-78. PubMed ID: 31597510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Mur Enzymes Chink in the Armour of Mycobacterium tuberculosis cell wall.
    Shinde Y; Ahmad I; Surana S; Patel H
    Eur J Med Chem; 2021 Oct; 222():113568. PubMed ID: 34118719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
    Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
    Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a one-pot assay for screening and identification of Mur pathway inhibitors in Mycobacterium tuberculosis.
    Eniyan K; Kumar A; Rayasam GV; Perdih A; Bajpai U
    Sci Rep; 2016 Oct; 6():35134. PubMed ID: 27734910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel multitarget antitubercular inhibitors against mycobacterial peptidoglycan biosynthetic Mur enzymes by structure-based virtual screening.
    Kumari M; Subbarao N
    J Biomol Struct Dyn; 2022 Nov; 40(18):8185-8196. PubMed ID: 33826470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
    Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of multi-target mur enzymes inhibitors with anti-mycobacterial activity through a Scaffold approach.
    Kumari M; Waseem M; Subbarao N
    J Biomol Struct Dyn; 2023 Apr; 41(7):2878-2899. PubMed ID: 35174764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and Synthesis of Various 5'-Deoxy-5'-(4-Substituted-1,2,3-Triazol-1-yl)-Uridine Analogues as Inhibitors of
    Hervin V; Arora R; Rani J; Ramchandran S; Bajpai U; Agrofoglio LA; Roy V
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33114668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G; Nallangi R; Devi PB; Saxena S; Yadav R; Sridevi JP; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Aug; 22(15):4223-32. PubMed ID: 24953948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis.
    Fakhar Z; Naiker S; Alves CN; Govender T; Maguire GE; Lameira J; Lamichhane G; Kruger HG; Honarparvar B
    J Biomol Struct Dyn; 2016 Nov; 34(11):2399-417. PubMed ID: 26612108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach.
    Uddin R; Zahra NU; Azam SS
    Comput Biol Chem; 2019 Apr; 79():91-102. PubMed ID: 30743161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the interaction mechanism between potential inhibitor and multi-target Mur enzymes of mycobacterium tuberculosis using molecular docking, molecular dynamics simulation, principal component analysis, free energy landscape, dynamic cross-correlation matrices, vector movements, and binding free energy calculation.
    Kumari M; Singh R; Subbarao N
    J Biomol Struct Dyn; 2022; 40(24):13497-13526. PubMed ID: 34662260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of potent chemical antituberculosis agents targeting Mycobacterium tuberculosis acetohydroxyacid synthase.
    Jung IP; Ha NR; Lee SC; Ryoo SW; Yoon MY
    Int J Antimicrob Agents; 2016 Sep; 48(3):247-58. PubMed ID: 27451857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Potential Inhibition of Candidate Drug Molecules for Clinical Investigation Based on their Docking or Crystallographic Analyses against
    Dey R; Nandi S; Samadder A; Saxena A; Saxena AK
    Curr Top Med Chem; 2020; 20(29):2662-2680. PubMed ID: 32885754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
    Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
    Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition.
    Mehra R; Rajput VS; Gupta M; Chib R; Kumar A; Wazir P; Khan IA; Nargotra A
    J Chem Inf Model; 2016 May; 56(5):930-40. PubMed ID: 27149193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis.
    Devi PB; Sridevi JP; Kakan SS; Saxena S; Jeankumar VU; Soni V; Anantaraju HS; Yogeeswari P; Sriram D
    Tuberculosis (Edinb); 2015 Dec; 95(6):786-794. PubMed ID: 26299907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities.
    Devi PB; Jogula S; Reddy AP; Saxena S; Sridevi JP; Sriram D; Yogeeswari P
    Mol Inform; 2015 Feb; 34(2-3):147-59. PubMed ID: 27490037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Mycobacterium tuberculosis CtpF as a target for designing new antituberculous compounds.
    Santos P; Lopez-Vallejo F; Ramírez D; Caballero J; Mata Espinosa D; Hernández-Pando R; Soto CY
    Bioorg Med Chem; 2020 Feb; 28(3):115256. PubMed ID: 31879181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.